These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 24480117)
1. Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway? Stockler-Pinto MB; Fouque D; Soulage CO; Croze M; Mafra D J Ren Nutr; 2014 Sep; 24(5):286-91. PubMed ID: 24480117 [TBL] [Abstract][Full Text] [Related]
2. Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases. Saito H Biochem Pharmacol; 2013 Apr; 85(7):865-72. PubMed ID: 23333765 [TBL] [Abstract][Full Text] [Related]
3. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Kim HJ; Vaziri ND Am J Physiol Renal Physiol; 2010 Mar; 298(3):F662-71. PubMed ID: 20007347 [TBL] [Abstract][Full Text] [Related]
4. Could physical exercises modulate Nrf2-Keap1 pathway in chronic kidney disease? Abreu CC; Cardozo LF; Mafra D Med Hypotheses; 2015 Jan; 84(1):44-6. PubMed ID: 25466297 [TBL] [Abstract][Full Text] [Related]
5. Nrf2-keap1 system versus NF-κB: the good and the evil in chronic kidney disease? Pedruzzi LM; Stockler-Pinto MB; Leite M; Mafra D Biochimie; 2012 Dec; 94(12):2461-6. PubMed ID: 22874821 [TBL] [Abstract][Full Text] [Related]
6. From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expression. Stockler-Pinto MB; Soulage CO; Borges NA; Cardozo LFMF; Dolenga CJ; Nakao LS; Pecoits-Filho R; Fouque D; Mafra D Int Urol Nephrol; 2018 Feb; 50(2):347-354. PubMed ID: 29151180 [TBL] [Abstract][Full Text] [Related]
7. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor. Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453 [TBL] [Abstract][Full Text] [Related]
8. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease. Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327 [TBL] [Abstract][Full Text] [Related]
9. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique. Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821 [TBL] [Abstract][Full Text] [Related]
10. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure. Lin CJ; Wu V; Wu PC; Wu CJ PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073 [TBL] [Abstract][Full Text] [Related]
12. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression. Nezu M; Suzuki N; Yamamoto M Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971 [TBL] [Abstract][Full Text] [Related]
13. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells. Yang SP; Yang XZ; Cao GP Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802 [TBL] [Abstract][Full Text] [Related]
14. Uremic Toxins and Vascular Dysfunction. Six I; Flissi N; Lenglet G; Louvet L; Kamel S; Gallet M; Massy ZA; Liabeuf S Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32570781 [TBL] [Abstract][Full Text] [Related]
15. LC-MS/MS method for simultaneous determination of serum p-cresyl sulfate and indoxyl sulfate in patients undergoing peritoneal dialysis. Shu C; Chen X; Xia T; Zhang F; Gao S; Chen W Biomed Chromatogr; 2016 Nov; 30(11):1782-1788. PubMed ID: 27129599 [TBL] [Abstract][Full Text] [Related]
16. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study. Crespo-Salgado J; Vehaskari VM; Stewart T; Ferris M; Zhang Q; Wang G; Blanchard EE; Taylor CM; Kallash M; Greenbaum LA; Aviles DH Microbiome; 2016 Sep; 4(1):50. PubMed ID: 27640125 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001 [TBL] [Abstract][Full Text] [Related]
18. Effect of Indoxyl Sulfate on the Repair and Intactness of Intestinal Epithelial Cells: Role of Reactive Oxygen Species' Release. Adesso S; Ruocco M; Rapa SF; Piaz FD; Raffaele Di Iorio B; Popolo A; Autore G; Nishijima F; Pinto A; Marzocco S Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31072046 [TBL] [Abstract][Full Text] [Related]
19. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells. Chen CS; Tseng YT; Hsu YY; Lo YC Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038 [TBL] [Abstract][Full Text] [Related]